Table 1.
Clinical characterization of Type 1 diabetic patients selected for the study
| Patients (M/F/Age in years) | BMI (kg/m2) | IFPG (mg/dL) | 2h IPG (mg/dL) | Insulin (μunits/dL) | Dermcidin (nM) | Polyuria | Polydipsia | Family History |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| 1. (M/34) | 20.4 | 175 | 200 | 11.5 | 112.5 | + | + | + |
| 2. (M/32) | 21.5 | 185 | 210 | 10.5 | 100.2 | + | + | + |
| 3. (M/23) | 19.9 | 170 | 205 | 12.5 | 115.6 | + | + | - |
| 4. (F/23) | 19.2 | 198 | 200 | 13.9 | 121.5 | - | - | - |
| 5. (F/24) | 18.5 | 199 | 215 | 14.25 | 120.5 | + | + | - |
| 6. (M/26) | 19.9 | 170 | 211 | 14 | 119.5 | - | - | - |
| 7. (F/28) | 20.1 | 175 | 200 | 15 | 110 | + | + | + |
| 8. (M/31) | 20.5 | 171 | 220 | 14.9 | 109.4 | + | + | - |
| 9. (F/32) | 21.9 | 172 | 215 | 14.5 | 98.4 | + | + | - |
| 10. (F/29) | 21.2 | 175 | 210 | 13 | 99.4 | + | + | + |
| 11. (M/28) | 19.2 | 179 | 200 | 13.25 | 169 | + | + | - |
| 12. (F/28) | 21 | 182 | 209 | 12.96 | 79 | - | - | - |
| 13. (F/30) | 21.2 | 195 | 220 | 11.25 | 89.9 | + | + | + |
| 14. (M/25) | 21 | 199 | 225 | 10.25 | 124.2 | + | + | + |
| 15. (M/26) | 21.2 | 183 | 215 | 10 | 119.6 | + | + | - |
| 16. (F/24) | 19.5 | 175 | 200 | 10.8 | 115.9 | - | - | - |
| 17. (M/28) | 19.9 | 170 | 214 | 11 | 107.4 | + | + | - |
| 18. (M/29) | 20.1 | 195 | 200 | 12.2 | 110.8 | - | - | - |
| 19. (F/31) | 18.5 | 170 | 205 | 13.25 | 106 | + | + | - |
| 20. (M/30) | 21 | 184 | 200 | 14.2 | 83.2 | + | + | + |
| 21. (M/33) | 21 | 185 | 217 | 14 | 85.5 | + | + | + |
| 22. (F/34) | 19.95 | 189 | 220 | 15.26 | 87.8 | + | + | + |
| 23. (M/35) | 20.4 | 190 | 200 | 11 | 98.9 | + | + | - |
| 24. (M/32) | 19.94 | 196 | 225 | 10.5 | 100.5 | + | + | - |
| 25. (M/35) | 21.2 | 170 | 229 | 10.25 | 89.9 | + | + | - |
| 26. (F/24) | 19.8 | 170 | 230 | 11.96 | 101.8 | + | + | - |
| 27. (M/36) | 21.1 | 171 | 200 | 12.58 | 124.8 | - | - | - |
| 28. (F/34) | 19.6 | 175 | 210 | 12.65 | 176 | + | + | + |
| 29. (F/32) | 20.5 | 186 | 205 | 13 | 165 | + | + | - |
| 30. (M/30) | 21 | 172 | 200 | 12 | 166 | + | + | - |
| 31. (F/29) | 18.8 | 170 | 220 | 10.25 | 164 | + | + | + |
| 32. (F/28) | 19.98 | 184 | 215 | 10.63 | 143 | + | + | - |
| 33. (M/25) | 21.1 | 175 | 217 | 15 | 130 | + | + | - |
| 34. (M/32) | 21 | 175 | 200 | 14.96 | 180 | + | + | + |
| 35. (F/26) | 21.1 | 193 | 200 | 14 | 99.9 | - | - | - |
| 36. (F/34) | 19.91 | 170 | 210 | 11.25 | 171.5 | + | + | - |
| 37. (M/27) | 21 | 185 | 205 | 10 | 167.7 | + | + | + |
| 38. (M/29) | 21 | 190 | 200 | 10 | 98.9 | + | + | + |
| 39. (F/30) | 21.2 | 175 | 214 | 10.91 | 142.8 | + | + | - |
| 40. (F/32) | 20.5 | 174 | 200 | 11.25 | 180 | + | + | + |
| 41. (M/33) | 21 | 175 | 207 | 12 | 139.9 | + | + | - |
| 42. (M/35) | 21 | 170 | 220 | 10 | 175 | + | + | - |
| 43. (F/29) | 21.2 | 185 | 215 | 11.25 | 143.5 | + | + | + |
| 44. (M/24) | 20.1 | 182 | 230 | 12.5 | 159.9 | - | - | - |
| 45. (M/32) | 21 | 183 | 220 | 10.5 | 166 | + | + | + |
The characterization of the T1DM patients as presented in the table were carried out following the guidelines of the American Diabetes Association. M, male; F, female as given within the parentheses; IFPG, Impaired Fasting Plasma Glucose level; IPG, Impaired Plasma Glucose level; BMI, body mass index.